Ledger.Open graph →
SEC Form D · filed May 19, 2017

CAPRICOR THERAPEUTICS, INC

Offering
$3.7M
Sold
$3.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BEVERLY HILLS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Frank Litvack · BEVERLY HILLS, CADirectorJoshua Kazam · New York, NYDirectorLouis Manzo · BEVERLY HILLS, CADirectorKaren Krasney · BEVERLY HILLS, CAExecLinda Marban · BEVERLY HILLS, CAExec · DirectorDavid Musket · BEVERLY HILLS, CADirectorGeorge Dunbar · Olivette, MODirectorAnthony Bergmann · BEVERLY HILLS, CAExecDeborah Ascheim · Beverly Hills, CAExecLeland Gershell · Beverly Hills, CAExecEarl Collier · BEVERLY HILLS, CADirectorRachel Smith · BEVERLY HILLS, CAExecFrank Litvack · Cambridge, MADirectorDeborah Ascheim · Beverly Hills, CAExecLeland Gershell · Beverly Hills, CAExecEarl Collier · BEVERLY HILLS, CADirectorJoshua Kazam · New York, NYDirectorLouis Manzo · BEVERLY HILLS, CADirectorRachel Smith · BEVERLY HILLS, CAExecKaren Krasney · BEVERLY HILLS, CAExecLinda Marban · BEVERLY HILLS, CAExec · DirectorDavid Musket · BEVERLY HILLS, CADirectorGeorge Dunbar · Ann Arbor, MIDirectorAnthony Bergmann · BEVERLY HILLS, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗